Dr. Jeremy A. Bergamo, MD

Dr. Bergamo practices at Florida Urology Specialists in Cape Coral, Florida.

Dr. Bergamo's NPI, 1619324019, was assigned on May 16, 2016. Dr. Bergamo graduated from University Of Florida College Of Medicine in 2016. Dr. Bergamo holds Florida license ME150870.

Dr. Bergamo's primary practice is Florida Urology Specialists, at 1419 SE 8th Ter, Cape Coral, FL 33990 in Lee County. The practice phone is (941) 309-7000.

Dr. Bergamo's primary practice is Florida Urology Specialists in Cape Coral, Florida. Dr. Bergamo is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is GenesisCare. Dmand AI also links Dr. Bergamo to 3 more hospitals, 3 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bergamo practices, 9 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Bergamo's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Bergamo is board certified in urology by the American Board of Urology. Dr. Bergamo is licensed in Florida.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Bergamo treats.

CMS data shows 10,853 Medicare services from Dr. Bergamo across 29 procedure codes in 2024, for 1,059 Medicare patients. Medicare paid $239,608 for them.

CMS counts 1,059 Medicare patients who saw Dr. Bergamo in 2024. The largest group is 75 to 84, with 472 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bergamo's median patient age at 75, with 21% women.

In 2024, Dr. Bergamo wrote 3,132 Medicare Part D claims for 786 patients. 86% of them were for generic drugs. CMS names the drug for 3,019 of them, across 38 drugs with 11 or more claims each, at $1,163,442 in total drug cost. In 2023, CMS named 2,309 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bergamo for performance year 2024, reported individually. Dr. Bergamo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Bergamo in 2020. Dr. Bergamo's most frequent co-authors are Christopher Edward Bayne, MD, Jeremy Michael Archer, MD and Romano T. Demarco, MD.

CMS Open Payments shows 130 general payments to Dr. Bergamo from 33 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. PROCEPT BioRobotics Corporation paid the most, $474.

Dr. Bergamo graduated from University Of Florida College Of Medicine in 2016.

Dr. Bergamo is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.